We are committed to improve patients’ life by delivering innovative cancer immunotherapies and treatments for neurologic disorders and rare diseases. We aim at making an impactful difference for patients suffering from cancer by discovering first-in-class and best-in-class treatments that tackle GPCR -mediated immunosuppression.
